Jan van der Meer

7.1k citations

102 papers · 5.1k indexed · 1 hit paper · h-index 36

Internal Medicine top 0.1%
Hematology top 0.2%
Cardiology and Cardiovascular Medicine top 1%
Surgery top 2%
Genetics top 5%

Co-authors: Nic J.G.M. Veeger Martin H. Prins Karly Hamulyák Harry R. Büller Jan‐Leendert P. Brouwer Saskia Middeldorp Maria M.W. Koopman Willem M. Lijfering
Topics: Blood Coagulation and Thrombosis Mechanisms (47 papers)Venous Thromboembolism Diagnosis and Management (32 papers)Hemophilia Treatment and Research (13 papers)
Cited by: Internal Medicine Hematology Cardiology and Cardiovascular Medicine
Journals: New England Journal of Medicine Circulation Journal of Clinical Oncology
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Jan van der Meer

98 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

1996 810 citations Maria M.W. Koopman, Paolo Prandoni et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Jan van der Meer

Since Specialization

Citations

This map shows the geographic impact of Jan van der Meer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van der Meer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van der Meer more than expected).

Fields of papers citing papers by Jan van der Meer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan van der Meer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van der Meer. The network helps show where Jan van der Meer may publish in the future.

Co-authorship network of co-authors of Jan van der Meer

This figure shows the co-authorship network connecting the top 25 collaborators of Jan van der Meer. A scholar is included among the top collaborators of Jan van der Meer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan van der Meer. Jan van der Meer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of 1025 fetal deaths: proposed diagnostic workup 2011 ·American Journal of Obstetrics and Gynecology ·Fleurisca J. Korteweg,Jan Jaap Erwich,Albertus Timmer,Jan van der Meer,Joke M. Ravisé,Nic J.G.M. Veeger,Jozien P. Holm	87
2	Transcriptome and membrane fatty acid analyses reveal different strategies for responding to permeating and non-permeating solutes in the bacterium Sphingomonas wittichii 2011 ·BMC Microbiology ·David R. Johnson,(unknown),(unknown),Hermann J. Heipieper,Jan van der Meer	34
3	Prevalence of Parental Thrombophilic Defects After Fetal Death and Relation to Cause 2010 ·Obstetrics and Gynecology ·Fleurisca J. Korteweg,Jan Jaap Erwich,Nienke Folkeringa,Albertus Timmer,Nic J.G.M. Veeger,Joke M. Ravisé,Jozien P. Holm,Jan van der Meer	15
4	Excellent Long-Term Clinical Outcome After Coronary Artery Bypass Surgery Using Three Pedicled Arterial Grafts in Patients With Three-Vessel Disease 2008 ·The Annals of Thoracic Surgery ·Nic J.G.M. Veeger,(unknown),Adriaan A. Voors,Jan G. Grandjean,Jan van der Meer,Piet W. Boonstra	9
5	Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels 2008 ·Thrombosis and Haemostasis ·Michiel Coppens,Nic J.G.M. Veeger,V J J Bom,(unknown),Karly Hamulyák,Martin H. Prins,H.R. Büller,Jan van der Meer,Nienke Folkeringa	20
6	PROS1analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations 2008 ·Human Mutation ·Min Ki ten Kate,Mathieu Platteel,René Mulder,P. Terpstra,Gerry A. F. Nicolaes,Pieter H. Reitsma,Gerrit van der Steege,Jan van der Meer	23
7	The Influence of NSAIDs on Coumarin Sensitivity in Patients with CYP2C9 Polymorphism After Total Hip Replacement Surgery 2007 ·Molecular Diagnosis & Therapy ·(unknown),(unknown),(unknown),Merel van Wijnen,Jan van der Meer,J. R. B. J. Brouwers	12
8	Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report 2007 ·Blood Coagulation & Fibrinolysis ·Willem M. Lijfering,Herman G. Sprenger,Willem J. van Son,Jan van der Meer	13
9	Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting 2007 ·Thrombosis and Haemostasis ·Elena Santagostino,A. Faradji,Alfonso Iorio,Jan van der Meer,Jørgen Ingerslev,Thierry Lambert,(unknown),Eduard Gorina,R Musso,(unknown)	35
10	Social challenges and organising capacity in cities : experiences in eight European cities 2003 ·Data Archiving and Networked Services (DANS) ·Leo van den Berg,Jan van der Meer,Peter M.J. Pol	5
11	Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation 2002 ·Hepatology ·Ton Lisman,Frank W.G. Leebeek,Karina Meijer,Jan van der Meer,(unknown),Philip G. de Groot	58
12	Protein C/S ratio, an accurate and simple tool to identify carriers of a protein C gene mutation 2002 ·British Journal of Haematology ·Eduard J. Libourel,Johan R. Meinardi,Pieter‐Jan de Kam,(unknown),(unknown),Marcel H.J. Ruiters,Jan van der Meer	1
13	The risk of pregnancy‐related venous thromboembolism in women who are homozygous for factor V Leiden 2001 ·British Journal of Haematology ·Saskia Middeldorp,Eduard J. Libourel,Karly Hamulyák,Jan van der Meer,H.R. Büller	60
14	REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION 2001 ·Transplantation ·Herman G. D. Hendriks,Karina Meijer,J. Th. M. de Wolf,I. J. Klompmaker,Robert J. Porte,Pieter Jan de Kam,(unknown),(unknown),Maarten J. H. Slooff,Jan van der Meer	196
15	Competitividad y cohesión metropolitanas: La exigencia de capacidad de organización y redes estratégicas 1999 ·Papeles de economía española ·Jan van der Meer,Erik Braun,(unknown)	3
16	Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study) 1997 ·The American Journal of Cardiology ·Werner Klein,Arnd B. Buchwald,W S Hillis,Scott Monrad,Ginés Sanz,Alexander G.G. Turpie,Jan van der Meer,(unknown),(unknown),Karin Ludwig	28
17	Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Homebreakdown → 1996 ·New England Journal of Medicine ·Maria M.W. Koopman,Paolo Prandoni,Franco Piovella,Paul Ockelford,Desiderius P.M. Brandjes,Jan van der Meer,Alexander Gallus,Gérald Simonneau,Colin Chesterman,Martin H. Prins,Patrick M. Bossuyt,Hanneke de Haes,A.G.M. van den Belt,Luc Sagnard,Pascal d’Azemar,Harry R. Büller	810
18	Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 year 1994 ·Journal of the American College of Cardiology ·Jan van der Meer,Aart Brutel de la Rivière,Wiek H. van Gilst,Hans L. Hillege,Matthias Pfisterer,(unknown),Peter H.J.M. Dunselman,Barbara J.M. Mulder,Kong I. Lie	20
19	Complement Activation and the Production of Inflammatory Mediators During the Treatment of Severe Sepsis in Humans 1992 ·Scandinavian Journal of Infectious Diseases ·Anthonius S. M. Dofferhoff,(unknown),V J J Bom,Jan van der Meer,(unknown),H. G. de Vries-Hospers,J. Marrink,Paula O.M. Mulder,J Weits	28
20	The City : engine behind economic recovery 1989 ·Leo H. Klaassen,Leo van den Berg,Jan van der Meer	4

About Jan van der Meer

Jan van der Meer is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 102 papers that have together received 5.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (47 papers), Venous Thromboembolism Diagnosis and Management (32 papers) and Hemophilia Treatment and Research (13 papers). The work is most often cited by research in Internal Medicine (2.4k citations), Hematology (2.1k citations) and Cardiology and Cardiovascular Medicine (2.1k citations). Jan van der Meer has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Nic J.G.M. Veeger, Martin H. Prins, Karly Hamulyák, Harry R. Büller, Jan‐Leendert P. Brouwer, Saskia Middeldorp, Maria M.W. Koopman, Willem M. Lijfering, Herman G. D. Hendriks and Maarten J. H. Slooff. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact